Home > Compound List > Product Information
Toloxatone_Molecular_structure_CAS_29218-27-7)
Click picture or here to close

Toloxatone

Catalog No. T3452 Name Sigma Aldrich
CAS Number 29218-27-7 Website http://www.sigmaaldrich.com
M. F. C11H13NO3 Telephone 1-800-521-8956
M. W. 207.22582 Fax
Purity ≥98% (HPLC) Email
Storage desiccated Chembase ID: 154083

SYNONYMS

IUPAC name
5-(hydroxymethyl)-3-(3-methylphenyl)-1,3-oxazolidin-2-one
IUPAC Traditional name
toloxatone
Synonyms
Humoryl
5-(hydroxymethyl)-3-(3-methylphenyl)-2-oxazolidinone

DATABASE IDS

MDL Number MFCD00865391
EC Number 249-522-2
CAS Number 29218-27-7

PROPERTIES

Empirical Formula (Hill Notation) C11H13NO3
Purity ≥98% (HPLC)
Apperance solid
Solubility DMSO: >10 mg/mL
GHS Pictograms GHS07
GHS Signal Word Warning
GHS Hazard statements H302
European Hazard Symbols Harmful Harmful (Xn)
MSDS Link Download
Personal Protective Equipment dust mask type N95 (US), Eyeshields, Gloves
Risk Statements 22
RTECS RQ2867500
Storage Condition desiccated
Storage Temperature 2-8°C
German water hazard class 3

DETAILS

Description (English)
Biochem/physiol Actions
Toloxatone is a reversible monoamine oxidase A inhibitor (MAOI) and antidepressant. Toloxatone belongs to the aryloxazolidinones, a relatively new class of reversible monoamine oxidase A inhibitors (MAOI). Studies show that derivatives such as 3-aryloxazolidin-2-one (oxazolidinones), which are regularly used to treat gram positive infections, represent a new class of reversible as well as irreversible inhibitors for MAO-A and MAO-B enzymes that are able to inhibit protein synthesis and also used for neurodegenerative-type pathologies.
Description (简体中文)
Biochem/physiol Actions
Toloxatone is a reversible monoamine oxidase A inhibitor (MAOI) and antidepressant. Toloxatone belongs to the aryloxazolidinones, a relatively new class of reversible monoamine oxidase A inhibitors (MAOI). Studies show that derivatives such as 3-aryloxazolidin-2-one (oxazolidinones), which are regularly used to treat gram positive infections, represent a new class of reversible as well as irreversible inhibitors for MAO-A and MAO-B enzymes that are able to inhibit protein synthesis and also used for neurodegenerative-type pathologies.

REFERENCES